Tower Research Capital LLC (TRC) - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 39 filers reported holding HEPION PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$8
-20.0%
10,564
-67.3%
0.00%
Q4 2022$10
-99.9%
32,289
+61.7%
0.00%
Q3 2022$10,000
+42.9%
19,966
+71.4%
0.00%
Q2 2022$7,000
+250.0%
11,648
+519.6%
0.00%
Q1 2022$2,000
-71.4%
1,880
-45.0%
0.00%
Q2 2021$7,000
-84.8%
3,418
-86.5%
0.00%
-100.0%
Q1 2021$46,000
+228.6%
25,308
+460.0%
0.00%
Q3 2020$14,0004,5190.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 57,309$178,0000.03%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 15,552$48,0000.00%
Squarepoint Ops LLC 15,524$48,0000.00%
ExodusPoint Capital Management, LP 11,632$36,0000.00%
BANK OF AMERICA CORP /DE/ 33,215$103,0000.00%
WELLS FARGO & COMPANY/MN 57$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 15,786$49,0000.00%
MILLENNIUM MANAGEMENT LLC 29,233$91,0000.00%
MORGAN STANLEY 54$00.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders